Profile data is unavailable for this security.
About the company
SCI Pharmtech, Inc. is a Taiwan-based company principally engaged in the processing, manufacture and sales of Active Pharmaceutical Ingredients (APIs). The Company's main products include APIs, API intermediates and special and precision chemicals. The Company distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
- Revenue in TWD (TTM)1.41bn
- Net income in TWD484.24m
- Incorporated1987
- Employees241.00
- LocationSCI Pharmtech IncNo. 186-2, Neighborhood 16, Hai-Hu-TsunTAOYUAN 338TaiwanTWN
- Phone+886 33543133
- Fax+886 33543483
- Websitehttp://www.sci-pharmtech.com.tw
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Panion & BF Biotech Inc | 2.01bn | 101.27m | 7.95bn | 321.00 | 78.52 | 4.29 | 29.15 | 3.96 | 1.18 | 1.18 | 23.42 | 21.62 | 0.6185 | 1.73 | 9.66 | -- | 3.12 | 4.08 | 4.82 | 5.63 | 52.66 | 52.37 | 5.04 | 5.93 | 0.8699 | 10.62 | 0.287 | 111.06 | -21.54 | 5.96 | -57.65 | -13.47 | 35.39 | -3.23 |
| Adimmune Corp | 1.66bn | -607.92m | 9.51bn | 564.00 | -- | 1.86 | -- | 5.74 | -1.44 | -1.44 | 3.93 | 11.92 | 0.1848 | 1.25 | 4.04 | -- | -8.27 | 0.6867 | -10.19 | 0.7739 | 27.82 | 30.11 | -44.75 | 3.04 | 1.99 | -24.75 | 0.3284 | 32.80 | -20.72 | 16.77 | -319.91 | -- | 38.05 | -- |
| Formosa Laboratories Inc | 4.69bn | 255.94m | 10.94bn | 480.00 | 43.10 | 1.46 | 18.23 | 2.33 | 2.11 | 2.11 | 38.90 | 62.49 | 0.3479 | 1.49 | 4.42 | -- | 0.7067 | 2.68 | 0.9689 | 3.61 | 44.30 | 35.40 | 2.03 | 8.75 | 1.18 | 0.8922 | 0.3155 | 27.38 | 15.80 | 10.16 | -69.16 | -6.52 | -11.60 | 32.22 |
| Standard Chem & Pharm Co Ltd | 6.71bn | 847.58m | 11.37bn | 1.13k | 13.42 | 1.92 | 7.10 | 1.69 | 4.74 | 4.74 | 37.50 | 33.05 | 0.6066 | 2.39 | 6.00 | -- | 10.98 | 9.68 | 20.02 | 17.61 | 43.81 | 43.75 | 18.10 | 17.02 | 1.93 | -- | 0.0795 | 60.34 | 6.64 | 11.80 | 2.39 | 17.40 | 29.97 | 12.47 |
| SCI Pharmtech Inc | 1.41bn | 484.24m | 11.47bn | 241.00 | 24.05 | 2.12 | 16.36 | 8.12 | 3.99 | 3.99 | 13.98 | 45.36 | 0.2211 | 1.82 | 4.61 | -- | 7.58 | 6.90 | 8.56 | 8.26 | 27.11 | 38.18 | 34.26 | 19.85 | 1.68 | 9.22 | 0.1692 | 42.38 | 33.83 | -9.10 | -4.55 | -8.00 | 44.67 | -16.35 |
| YungShin Global Holding Corp | 7.44bn | 1.05bn | 14.47bn | 1.57k | 13.74 | 1.96 | 10.18 | 1.95 | 3.95 | 3.95 | 27.91 | 27.66 | 0.5953 | 1.47 | 5.51 | -- | 9.10 | 6.64 | 13.58 | 10.20 | 43.28 | 45.11 | 15.29 | 10.45 | 1.35 | -- | 0.1034 | 70.94 | -3.88 | -1.33 | -1.40 | 3.34 | -29.00 | 0.893 |
Data as of Nov 14 2024. Currency figures normalised to SCI Pharmtech Inc's reporting currency: Taiwan Dollar TWD
0.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 582.97k | 0.49% |
| Dimensional Fund Advisors Ltd.as of 31 Aug 2024 | 48.27k | 0.04% |
| SSgA Funds Management, Inc.as of 03 Oct 2024 | 43.16k | 0.04% |
| DFA Australia Ltd.as of 30 Sep 2024 | 8.00k | 0.01% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
